GokMKundiHKiziltuncETopcuogluCOrnekE. Endocan levels and coronary collateral circulation in stable angina pectoris: a pilot study. Angiology. 2018;69(1):43–48.
2.
SeilerCStollerMPittBMeierP. The human coronary collateral circulation: development and clinical importance. Eur Heart J. 2013;34(34):2674–2682.
3.
AkbogaMKYalcinRSahinarslanAYilmaz DemirtasCAbaciA. Effect of serum YKL-40 on coronary collateral development and SYNTAX score in stable coronary artery disease. Int J Cardiol. 2016;224:323–327.
4.
AkboğaMKTaçoyGYilmaz DemirtaşCTürkoğluSBoyaciBÇengelA. As cardioprotective and angiogenic biomarker, can ghrelin predict coronary collateral development and severity of coronary atherosclerosis?[in Turkish]. Turk Kardiyol Dern Ars. 2017;45(4):316–323.
5.
MenonPKocherONAirdWC. Endothelial cell specific molecule-1 (ESM-1), a novel secreted proteoglycan stimulates vascular smooth muscle cell proliferation and migration. Circulation. 2011;124(21):a15455.
6.
BaltaSMikhailidisDPDemirkolS, et al.Endocan—a novel inflammatory indicator in newly diagnosed patients with hypertension: a pilot study. Angiology. 2014;65(9):773–777.
7.
YilmazMISiriopolDSaglamM, et al.Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease. Kidney Int. 2014;86(6):1213–1220.
8.
AlsancakYCengelAAkyelA, et al.Relationship between serum vitamin D levels and angiographic severity and extent of coronary artery disease. Eur J Clin Invest. 2015;45(9):940–948.
9.
YilmazSAkbogaMKSenF, et al.Usefulness of the monocyte-to-high-density lipoprotein cholesterol ratio to predict bare metal stent restenosis. Biomark Med. 2016;10(9):959–966.
10.
EmetSElitokAOnurI, et al.Endocan: a novel biomarker associated with well-developed coronary collateral circulation in patients with stable angina and chronic total occlusion. J Thromb Thrombolysis. 2017;43(1):60–66.
